DAM
ACXP icon

Draper Asset Management’s Acurx Pharmaceuticals ACXP Stock Holding History

Draper Asset Management’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,301
Closed -$1.06M – 38
2022
Q4 		$1.06M Hold
13,301
– – 1.47% 10
2022
Q3 		$798K Hold
13,301
– – 0.97% 15
2022
Q2 		$1.01M Hold
13,301
– – 1.18% 12
2022
Q1 		$873K Buy
+13,301
New +$1.04M 0.72% 16

Other funds holding ACXP

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Draper Asset Management's ACXP Position: Q1 2023 in Review

Draper Asset Management sold out of Acurx Pharmaceuticals (ACXP) in Q1 2023, closing a stake of 13,301 shares — an estimated $1.06M sold.

Draper Asset Management first reported a position in ACXP in Q1 2022 and held it in 4 quarters. The position peaked at $1.06M in Q4 2022. 12 funds tracked by Wall St. Rank hold ACXP as of Q1 2023.

  • Draper Asset Management reported no remaining Acurx Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Draper Asset Management sold 13,301 Acurx Pharmaceuticals shares in Q1 2023, an estimated $1.06M.
  • Draper Asset Management first reported a position in Acurx Pharmaceuticals in Q1 2022 and held it in 4 quarters.
  • Draper Asset Management's Acurx Pharmaceuticals position peaked at $1.06M in Q4 2022.
  • 12 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q1 2023.

Based on Draper Asset Management's 13F filing for Q1 2023, filed 8 May 2023.